publication venue for
- A prognostic score to identify women at increased risk for uterine bleeding during anticoagulation for venous thromboembolism.. 100148-100154. 2023
- Age over 75 does not increase the risk of recurrent venous thromboembolism: Findings from the RIETE registry. 16-19. 2023
- Enoxaparin for the long-term therapy of venous thromboembolism in patients with cancer and renal insufficiency 2023
- Enoxaparin for the long-term therapy of venous thromboembolism in patients with cancer and renal insufficiency.. 1-12. 2023
- Feasibility of a screening algorithm for chronic thromboembolic pulmonary hypertension: The OSIRIS study. 1-9. 2023
- Feasibility of a screening algorithm for chronic thromboembolic pulmonary hypertension: The OSIRIS study. . 1-9. 2023
- Identifying patients with prostate cancer at increased risk for haematuria during anticoagulation for venous thromboembolism 2023
- Identifying patients with prostate cancer at increased risk for haematuria during anticoagulation for venous thromboembolism. . 54-61. 2023
- The value of the CHAP model for prediction of the bleeding risk in patients with unprovoked venous thromboembolism: Findings from the RIETE registry. 17-20. 2023
- A RIETE registry analysis of patients with upper extremity deep vein thrombosis and thoracic outlet syndrome. 65-70. 2022
- Clinical characteristics, time course, and outcomes of major bleeding according to bleeding site in patients with venous thromboembolism. 10-18. 2022
- Major gastrointestinal bleeding in patients receiving anticoagulant therapy for venous thromboembolism. 29-36. 2022
- Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis. 69-74. 2022
- Difference between Japanese and White Patients with Acute Pulmonary Embolism.. 52-56. 2021
- Impact of sex,age, and risk factorsfor venous thromboembolismon theinitial presentationof first isolated symptomatic acute deep vein thrombosis. 166-171. 2021
- Outcomes during anticoagulation in patients with symptomatic vs.incidental splanchnic vein thrombosis. 69-74. 2021
- Outcomes in patients with acute pulmonary embolism and patent foramen ovale: Findings from the RIETE registry. 59-66. 2021
- Venous thromboembolism in solid-organ transplant recipients: Findings from the RIETE registry. 131-138. 2021
- Evaluation of the SAMe-TT2R2 score to predict the quality of anticoagulation control in patients with venous thromboembolism treated with vitamin K antagonists: findings from the RIETE registry. 178-182. 2020
- Long-term bleeding risk vs. mortality risk in acute coronary syndrome patients according to the 2019 ARC-HBR definition. 1-3. 2020
- Management and outcomes of cancer patients with venous thromboembolism presenting with thrombocytopenia. . 178-182. 2020
- Outcome of patients with acute symptomatic pulmonary embolism and psychiatric disorders. 90-97. 2020
- Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism. 160-165. 2020
- Impact of sex, age, and risk factors for venous thromboembolism on the initial presentation of first isolated symptomatic acute deep vein thrombosis. . 166-171. 2019
- Management and outcome of major bleeding in patients receiving vitamin K antagonists for venous thromboembolism. 74-80. 2018
- Outcome during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis. 69-74. 2018
- Gender differences in patients with venous thromboembolism and five common sites of cáncer. . 16-20. 2017
- Gender-related differences in the outcome of patients with venous thromboembolism and thrombophilia. 11-15. 2017
- Outcome after discontinuing anticoagulant therapy in women with venous thromboembolism during hormonal use. 6-10. 2017
- Uterine bleeding during anticoagulation in women with venous thromboembolism. 1-5. 2017
- Plasma levels of von Willebrand factor are increased in patients with hypertrophic cardiomyopathy.. 46-50. 2016
- Duration of anticoagulation after venous thromboembolism in real world clinical practice . 666-672. 2015
- Fondaparinux in the initial and long-term treatment of venous thromboembolism. . 311-317. 2015
- Gender differences in cáncer patients with acute venous thromboembolism.. 12-15. 2015
- Venous thromboembolism in patients with glioblastoma multiforme: Findings of the RIETE Registry 2015
- D-dimer levels and 90-day outcome in patients with acute pulmonary embolism with or without cancer. 384-389. 2014
- Influence of recent immobilization or surgery on mortality in cancer patients with venous thromboembolism. 29-34. 2014
- Factors associated with elevated pulmonary arterial pressure levels on the echocardiographic assessment in patients with prior pulmonary embolism. 191-195. 2013
- Three-month mortality rate and clinical predictors in patients with venous thromboembolism and cancer. Findings from the RIETE registry. 24-30. 2013
- Validation of a score for predicting fatal bleeding in patients receiving anticoagulation for venous thromboembolism. 834-843. 2013
- . Long-term Therapy with low-molecular-weight heparin in cancer patients with venous thromboembolism. 37-43. 2012
- Unsuspected pulmonary embolism in patients with cancer. 16-19. 2012
- Venous thromboembolism in immobilized patients with dementia. Findings from the RIETE Registry. 173-177. 2012
- Thirty-day mortality rate in women with cancer and venous thromboembolism. Findings from the RIETE registry. 1-4. 2011
- Bleeding complications associated with anticoagulant therapy in patients with cancer. . 58-63. 2010
- Clinical characteristics and outcome of patients with factor V Leiden or prothrombin G20210A and a first episode of venous thromboembolism. Findings from the RIETE Registry.. 283-286. 2010
- Prolonged travel and venous thromboembolism. Findings from the RIETE Registry.. 287-291. 2010